tiprankstipranks
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market
BBOT
BridgeBio Oncology Therapeutics
RESEARCH TOOLSreports
Want to see BBOT full AI Analyst Report?

BridgeBio Oncology Therapeutics (BBOT) Financial Statements

57 Followers

BridgeBio Oncology Therapeutics Financial Overview

BridgeBio Oncology Therapeutics's market cap is currently $705.74M. The company's EPS TTM is $; its P/E ratio is -4.25; BridgeBio Oncology Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -145.82M$ -80.86M$ -64.77M$ -3.52K$ -43.36K
EBITDA$ -145.21M$ -80.66M$ -64.68M$ -3.52K$ -43.36K
Net Income$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Balance Sheet
Cash & Short-Term Investments$ 425.46M$ 1.70M$ 0.00$ 0.00$ 0.00
Total Assets$ 448.38M$ 194.42M$ 332.89K$ 144.58K$ 144.28K
Total Debt$ 2.77M$ 0.00$ 70.09K$ 43.11K$ 36.96K
Net Debt$ -370.92M$ -1.70M$ 70.09K$ 43.11K$ 36.96K
Total Liabilities$ 37.28M$ 5.71M$ 396.46K$ 166.46K$ 162.64K
Stockholders' Equity$ 411.10M$ 188.72M$ -63.57K$ -21.88K$ -18.36K
Cash Flow
Free Cash Flow$ -114.50M$ -763.82K$ 0.00$ 0.00$ 0.00
Operating Cash Flow$ -113.89M$ -763.82K$ 0.00$ 0.00$ 0.00
Investing Cash Flow$ 73.33M$ -184.00M$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 383.40M$ 186.46M$ 0.00$ 0.00$ 0.00
Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History

Income Statement >

BridgeBio Oncology Therapeutics Debt to Assets

Balance Sheet >

BridgeBio Oncology Therapeutics Cash Flow

Cash Flow >

BridgeBio Oncology Therapeutics Forecast EPS vs Actual EPS

Earnings >